Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Global DECS Corp. Announces Management Changes, Agreement to Acquire AIDS Vaccine and Biomedical Assets.


Business Editors

LA JOLLA, Calif.--(BUSINESS WIRE)--Nov. 19, 2001

Global DECS DECS Department of Education, Culture and Sports (Filipino; Kagawaran ng Edukasyon, Kultura at Palakasan; Philippines)
DECS Domino Enterprise Connection Services (Lotus) 
 Corp. ("GDEC GDEC Group DeCorrelator " or the "Company") (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:GDEC) announced management changes with the appointment of a new Chairman, CEO/President and Chief Financial Officer, as well as the resignations of existing directors. The company will enter the Biotech field, and has entered into an agreement to acquire an anti-viral therapeutic AIDS vaccine AIDS vaccine A hypothetical vaccine intended to either prevent HIV infection or ensure that those infected will not fall victim to AIDS; the most promising vaccine is that using a naked DNA plasmid, reported by Letwin et al in 20/10/00 Science; as of early 2001, , transdermal patch transdermal patch: see skin patch.  technology, related license agreements, patents and other assets other assets

Assets of relatively small value. For financial reporting purposes, firms frequently combine small assets into a single category rather than listing each item separately.
 of Vector Medical Technologies Inc., a privately held Biotech company based in Boca Raton, Florida Boca Raton ("bōkə rə-tōn") is a city in Palm Beach County, Florida incorporated in May 1925. As of the 2000 census, the city had a total population of 74,764; the 2006 population recorded by the U.S. Census Bureau was 86,396. .

Vector is a development stage biopharmaceutical technology company focused on the commercial development, marketing, and distribution of products created from two biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 breakthroughs. The first is a method of delivering ethical drugs into the human body, through the use of a biopolymer bi·o·pol·y·mer
n.
A macromolecule, such as a protein or nucleic acid, that is formed in a living organism.



biopolymer

any protein or nucleic acid produced by a living organism.
 that transmits macromolecule macromolecule, term that may refer either to a crystal such as a diamond, in which the atoms are identical and held by covalent bonds (see chemical bond) of equal strength, or to one of the units that compose a polymer.  drugs into the body. Vector has contracted for an exclusive license and an option to purchase the patent and related rights for the technology regarding a transdermal patch that may be placed on the skin, which is capable of delivering into the body large molecule drugs, such as insulin. Vector has also used this technology in creating a facial cream product that removes wrinkles and sagging skin designed for the cosmetics industry, which is marketed under the name GENERATIONS.

Vector's second medical breakthrough is a patented anti-viral therapeutic AIDS vaccine, that enhances the body's immune system and stimulates the growth of T cells and NK cells (so called "natural killer" cells), which has been shown in clinical trials on humans to eradicate the deadly AIDS Virus without any known adverse side-affects being detected to date.

GDEC obtained the right to purchase all of Vectors assets in exchange for 55,000,000 newly issued restricted common shares of GDEC, and the assumption of the purchase obligations pursuant to an asset purchase agreement, assigned to GDEC by Antonia Finance Limited. The assigned asset purchase agreement contains certain conditions, which upon completion are expected to result in the acquisition of the Vector assets by GDEC, free and clear of any liabilities. The significant conditions required in order to complete the Vector asset purchase by GDEC include the following:

-- Vector calling a shareholder meeting to seek shareholders approval for the sale of the Vector assets. Shareholders representing a majority of Vector's voting shares have irrevocably agreed to vote in favor of approving the sale.

-- Vector is to receive either $49,900,000 in cash, as the balance of a $50,000,000 purchase price for the assets, or in the alternative, GDEC may elect to pay only $1,150,000 in cash, assume certain Vector debt and issue $30,000,000 in restricted shares of common stock of GDEC to Vector. The number of GDEC shares shall be calculated based upon the bid price on the closing date. Detailed information relating to the asset purchase agreement can be reviewed on the exhibits to Form 8-K, as filed by GDEC with the Securities and Exchange Commission, dated November 19.

At a Special Meeting of the Board of Directors of GDEC held on November 7, the Board of Directors appointed three new officers and directors of GDEC with immediate effect at the conclusion of the meeting. Williard Wiens, Jim Mitchell, and Murray Johns all resigned as officers and directors of GDEC. The newly elected officers and directors are:

-- Malcolm J. Gold, (aged 57) a British citizen, has been appointed as Chairman and a director. He has served as Chairman of two London Stock Exchange London Stock Exchange

London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses.
 companies, in the hospitality business.

-- Johann A. De Villiers, (aged 48) a resident of California, has accepted the appointment as President, Chief Executive Officer, and a director. He is an experienced CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  having run investment banking, and public mining companies, with degrees in accounting and business management from the Witwaters Rand University, South Africa. De Villiers has experience in mutual fund management, investment banking and was a member of the American Stock Exchange American Stock Exchange (AMEX)

Stock exchange in the U.S. Originally known as “the Curb,” it began as an outdoor marketplace in New York City c. 1850. It moved indoors to its present location in the Wall Street area in 1921.
, for five years.

-- Eugene L. Brill, (aged 36) a resident of California, is Chief Financial Officer, Secretary, and a director. He has 15 years experience as an equity fund manager, corporate financier and chief financial officer of publicly traded Global Diamonds Inc. Brill is a member of the national association of securities dealers National Association of Securities Dealers (NASD)

Nonprofit organization formed under the joint sponsorship of the investment bankers' conference and the SEC to comply with the Maloney Act, which provides for the regulation of the OTC market.
, holding series 7, 4, 63, and 24-licenses, since 1993.

Forward-Looking Statements

Certain statements included in this press release are "forward-looking" statements, such as those relating to anticipate future revenue of the Company or the anticipated success of current product offerings. Such forward-looking statements involve important risks and uncertainties that could significantly affect anticipated results in the future. The Company's performance and financial results could differ materially from those reflected in the forward-looking statements due to financial, economic, regulatory and political conditions or additional factors unknown to the Company at this time. Therefore, current or prospective investors are cautioned not to place undue reliance on any such forward-looking statements. The Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 19, 2001
Words:841
Previous Article:Top Electricity and Natural Gas Executives To Address Tumultuous Changes in Deregulated Markets at Platts' 8th Annual Day of the Trader Conference.
Next Article:Inceptor Helps Verizon Wireless Connect With Their Online Customers; Inceptor's Excedia Optimizes Online Visibility, Drives Up Traffic Significantly.



Related Articles
Human test of AIDS vaccine approved.
AIDS meeting suggests basic research gaps.
Report condemns NIH role in AIDS trials.
Two steps forward in AIDS vaccine search.
NIH advisers endorse disputed vaccine trial.
First HIV Vaccine for Africa Begins Trials.
CHECKUP : NOBEL LAUREATE EXPECTS AIDS VACCINE.
VOLUNTEERS OFFER TO RISK LIVE-VIRUS AIDS VACCINE ASSOCIATED PRESS.
Army Dental Research?

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles